Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesisVITALE-CROSS, Lynn; AMORNPHIMOLTHAM, Panomwat; FISHER, Galen et al.Cancer research (Baltimore). 2004, Vol 64, Num 24, pp 8804-8807, issn 0008-5472, 4 p.Article

Inducible activation of oncogenic K-ras results in tumor formation in the oral cavityCAULIN, Carlos; NGUYEN, Thao; LONGLEY, Mary A et al.Cancer research (Baltimore). 2004, Vol 64, Num 15, pp 5054-5058, issn 0008-5472, 5 p.Article

Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient = Activation maligne d'un oncogène K-ras dans le cancer du poumon mais pas dans le tissu normal du même maladeSANTOS, E; MARTIN-ZANCA, D; PREMKUMAR REDDY, E et al.Science (Washington, D.C.). 1984, Vol 223, Num 4637, pp 661-664, issn 0036-8075Article

Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cellsAGBUNAG, Cristina; BAR-SAGI, Dafna.Cancer research (Baltimore). 2004, Vol 64, Num 16, pp 5659-5663, issn 0008-5472, 5 p.Article

Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumorsYALI XIE; HANJING YANG; MILLER, Jeffrey H et al.Cancer research (Baltimore). 2004, Vol 64, Num 9, pp 3096-3102, issn 0008-5472, 7 p.Article

B-Raf is dispensable for k-ras-mediated oncogenesis in human cancer cellsKIM, Jung-Sik; LEE, Carolyn; FOXWORTH, Aaron et al.Cancer research (Baltimore). 2004, Vol 64, Num 6, pp 1932-1937, issn 0008-5472, 6 p.Article

Valeur pronostique des mutations du gène K-RAS dans le cancer colorectal = Prognostic value of K-RAS mutation in colorectal cancerCEROTTINI, J. P; GIVEL, J. C; BENHATTAR, J et al.Swiss surgery. 1995, Num 6, pp 304-306, issn 1023-9332Article

Inactivating Icmt ameliorates K-RAS-induced myeloproliferative diseaseWAHLSTROM, Annika M; CUTTS, Briony A; MENG LIU et al.Blood. 2008, Vol 112, Num 4, pp 1357-1365, issn 0006-4971, 9 p.Article

Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lungRODENHUIS, S; SLEBOS, R. J. C; BOOT, A. J. M et al.Cancer research (Baltimore). 1988, Vol 48, Num 20, pp 5738-5741, issn 0008-5472Article

STAT3 Plays a Critical Role in KRAS-Induced Pancreatic TumorigenesisCORCORAN, Ryan B; CONTINO, Gianmarco; DESHPANDE, Vikram et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 14, pp 5020-5029, issn 0008-5472, 10 p.Article

Rapid and sensitive nonradioactive detection of mutant K-ras genes via «enriched» PCR amplificationKAHN, S. M; WEI JIANG; CULBERTSON, T. A et al.Oncogene : (Basingstoke). 1991, Vol 6, Num 6, pp 1079-1083Article

Neoplastic transformation of endocervicosis into an extraovarian mucinous cystadenocarcinomaKRUSE, Arnold-Jan; SLANGEN, Brigitte; DUNSELMAN, Gerard A et al.Human pathology. 2011, Vol 42, Num 5, pp 743-748, issn 0046-8177, 6 p.Article

Clinical Relevance of KRAS in Human CancersJANCIK, Sylwia; DRABEK, Jiří; RADZIOCH, Danuta et al.Journal of Biomedicine and Biotechnology (Print). 2010, Vol 2010, issn 1110-7243, 150960.1-150960.13, 2Article

K-ras codon-specific mutations produce distinctive metabolic phenotypes in human fibroblastsVIZAN, Pedro; BOROS, Laszlo G; FIGUERAS, Agnes et al.Cancer research (Baltimore). 2005, Vol 65, Num 13, pp 5512-5515, issn 0008-5472, 4 p.Article

KRAS Mutation: Should We Test for It, and Does It Matter?ROBERTS, Patrick J; STINCHCOMBE, Thomas E.Journal of clinical oncology. 2013, Vol 31, Num 8, pp 1112-1120, issn 0732-183X, 9 p.Article

Oncogenic Kras Promotes Chemotherapy-Induced Growth Factor Shedding via ADAM17VAN SCHAEYBROECK, Sandra; KYULA, Joan N; FENTON, Audrey et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 3, pp 1071-1080, issn 0008-5472, 10 p.Article

Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutationsZENKER, Martin; LEHMANN, Katarina; MUNDLOS, Stefan et al.Journal of medical genetics. 2007, Vol 44, Num 2, pp 131-135, issn 0022-2593, 5 p.Article

Etudes structurales par RMN d'oligonucléotides contenant soit une paire de bases non complémentaires soit une lacune d'un nucléotide = NMR structural studies of oligonucleotides containing non complementary bases pairs or a one nucleotide gapFaibis, Valérie; Fazakerley, V.1996, 151 p.Thesis

Tissue-specific hypomethylation of the human c-K-ras geneMETTER, J; CHONG CHO.Nucleic acids research. 1989, Vol 17, Num 17, pp 7089-7099, issn 0305-1048Article

Somatic activation of ras^K gene in a human ovarian carcinoma = Activation somatique du gène rasK dans un cancer de l'ovaire humainFEIG, L. A; BAST, R. C. JR; KNAPP, R. C et al.Science (Washington, D.C.). 1984, Vol 223, Num 4637, pp 698-701, issn 0036-8075Article

A cell line from a human ovarian carcinoma with amplification of the K-ras geneFILMUS, J; TRENT, J. M; PULLANO, R et al.Cancer research (Baltimore). 1986, Vol 46, Num 10, pp 5179-5182, issn 0008-5472Article

4-Hydroxytamoxifen Induces Autophagic Death through K-Ras DegradationKOHLI, Latika; KAZA, Niroop; CORIC, Tatjana et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 14, pp 4395-4405, issn 0008-5472, 11 p.Article

KRAS mutations in historical tumour specimens of the Viennese Museum of pathological anatomySEDIVY, Roland; KALIPCIYAN, Maria; PATZAK, Beatrix et al.Histopathology. 2011, Vol 58, Num 5, pp 792-796, issn 0309-0167, 5 p.Article

PCR bias toward the wild-type k-ras and p53 sequences : Implications for PCR detection of mutations and cancer diagnosisBARNARD, R; FUTO, V; PECHENIUK, N et al.BioTechniques. 1998, Vol 25, Num 4, pp 684-691, issn 0736-6205, 7 p.Article

Ras and myelodysplasia : Lessons from the last decadePARKER, J; MUFTI, G. J.Seminars in hematology. 1996, Vol 33, Num 3, pp 206-224, issn 0037-1963Article